AI in Pharma Manufacturing Market Research 2026-2040: Pfizer, Moderna, Novartis, Merck, and Sanofi are Integrating AI Into Their Operations As the Sector Evolves Towards Pharma 4.0

AI revolutionizes pharma manufacturing by enhancing efficiency, quality, and cost-effectiveness. Key opportunities include predictive maintenance, real-time quality control, and supply chain optimization. Major firms leverage AI to remain competitive, with notable growth expected in Asia-Pacific due to digitalization efforts.

Dublin, March 03, 2026 (GLOBE NEWSWIRE) -- The "AI in Pharma Manufacturing Market, till 2040: Distribution by Type of Offering, Mode of Deployment, Type of AI Solution, Type of Technology, Application Area, Utility in Drug Manufacturing, Geographical Regions and Key Players" report has been added to ResearchAndMarkets.com's offering.

The global AI in pharma manufacturing market size is estimated to grow from USD 1.20 billion in the current year to USD 34.7 billion by 2040, at a CAGR of 28% during the forecast period, till 2040. The new study provides market size, growth scenarios, industry trends and future forecasts.

Artificial Intelligence (AI) is a subdivision of computer science that enables computers to perform intricate tasks that usually require human intelligence, including learning, reasoning, and making decisions. In the healthcare sector, AI is already being applied in various areas such as drug discovery, clinical trials, diagnostics, personalized medicine, and data management. Within pharmaceutical manufacturing, AI utilizes technologies like computer vision, machine learning, generative AI, and deep learning to improve process monitoring, identify inefficiencies, lower production costs, and enhance product yield.

Pharmaceutical manufacturing faces numerous inefficiencies, including inefficient workflows, equipment downtime, quality control issues, and supply chain interruptions. These inefficiencies can result in higher costs, production delays, and variability in product quality. AI addresses these challenges by enabling process optimization, monitoring the performance of plants and equipment, anticipating equipment failures beforehand, managing supply chains, and automating quality control processes. Several pharmaceutical companies, including Pfizer , Moderna, Novartis , Merck KGaA , and Sanofi, are integrating AI into their manufacturing operations as the sector evolves towards Pharma 4.0.

Key Drivers Propelling Growth of AI in Pharma Manufacturing Market

The growth of AI in the drug manufacturing sector is driven by an increasing demand for enhanced process efficiency, lower production costs, and the maintenance of consistent product quality. Additionally, rising regulatory support and the ongoing digital transformation within the pharmaceutical industry further promotes the adoption of cutting-edge AI technologies.

It is worth noting that AI applications in drug manufacturing encompass a range of functions, including quality control, predictive maintenance, process development and optimization, monitoring of plant and equipment performance, as well as supply chain optimization. The broadening range of these applications continues to propel substantial market demand for AI solutions specifically designed for pharmaceutical manufacturing.

AI in Pharma Manufacturing Evolution: Emerging Trends in the Industry

AI is transforming pharmaceutical manufacturing by making processes smarter, faster, and more reliable. Emerging trends include predictive maintenance using machine learning to spot equipment issues early, cutting downtime and costs. Real-time quality control with AI vision detects defects like cracks or contamination instantly in production lines, ensuring consistent drug quality and regulatory compliance.

Process optimization employs advanced controls and digital twins to fine-tune parameters such as temperature and mixing, boosting efficiency and reducing waste. AI combined with robotics and IoT enables automated labs of the future for continuous monitoring and adaptive production. These innovations help pharma companies to produce safer medicines quicker while saving money and meeting strict standards.

Key Market Challenges

The market for AI in pharma manufacturing faces significant challenges that slow its adoption. One of the primary challenges is data issues, with poor quality, biases, silos, and limited availability making AI models unreliable for precise production tasks. High costs for setup, integration with old systems, and ongoing maintenance strain budgets, especially for smaller firms hindering the adoption of such technologies.

Additionally, strict regulations like GMP and FDA rules demand validation, transparency, and compliance, but AI's "black box" nature complicates approvals and ethics. Moreover, shortage of personnel skilled in both AI and pharmaceutical expertise hampers effective deployment of AI in the pharmaceutical manufacturing domain.

AI in Pharma Manufacturing Market: Competitive Landscape of Companies in this Industry

The present market environment consists of approximately 130 participants, including major, large, medium, and small enterprises. These organizations possess the necessary skills to deliver AI solutions for drug production across various geographical areas.

Importantly, over 95% of the companies involved in AI for drug production provide advanced software solutions. Further, nearly 80% of these firms are implementing machine learning to digitize various phases of the drug manufacturing process.

Regional Analysis: Asia-Pacific to Propel the market growth in the Coming Years

According to our projections, currently North America captures the majority of the market, and this trend is unlikely to change in the future as well. This is due to the presence of advanced pharma manufacturing infrastructure, early adoption of artificial intelligence (AI) in healthcare technologies and supportive regulatory framework across the region.

However, it is worth highlighting that the market in Asia-Pacific is expected to grow at a higher CAGR during the forecast period. This is driven by the lower implementation costs, supportive government policies fostering digitalization, and rapidly expanding pharmaceutical sector.

Strategic Insights for Senior Leaders

What are the Use Cases of Artificial Intelligence in Pharmaceutical Manufacturing?
More than 60% of major pharmaceutical companies are utilizing AI to revolutionize their manufacturing processes, improving efficiency, quality, and flexibility. Prominent applications include real-time monitoring, automated quality inspections, predictive maintenance, and optimization of the supply chain.

For example, Sanofi applies AI to enhance production yield and process effectiveness; Novartis uses machine learning techniques for real-time monitoring of plants and AI-powered supply chain optimization in drug production; Merck KGaA utilizes AI to decrease false reject rates in quality assessments; and Moderna leverages AI-based tools to improve quality control systems. These technologies not only streamline processes but also lead to cost savings and a better regulatory environment for AI in the drug manufacturing sector.

As top pharmaceutical firms and AI solution providers continue to develop their capabilities, incorporating AI into drug manufacturing has become essential for achieving operational excellence and sustaining a competitive advantage in this swiftly changing industry.

Key Questions Answered in this Report

• What is the current and future market size?
• Who are the leading companies in this market?
• What are the growth drivers that are likely to influence the evolution of this market?
• What are the key partnership and funding trends shaping this industry?
• Which region is likely to grow at higher CAGR till 2040?
• How is the current and future market opportunity likely to be distributed across key market segments?

Companies Featured

• C3.AI
• AMD
• IBM
• Kalypso
• SAS Institute
• Korber Pharma
• SDG Group
• Catalyx
• Elisa Industriq
• Straive
• Axiomtek
• Appinventiv
• Amplelogic
• Precognize

AI in Pharma Manufacturing Market: Key Market Segmentation

Type of Offering

• Hardware
• Software AG
• Services

Mode of Deployment

• Cloud
• On-premise

Type of AI Solution

• Standard / Off-the-shelf AI solutions
• Personalized AI solutions

Type of Technology

• Computer Vision
• Deep Learning
• Generative AI
• Machine Learning
• Other Technologies

Application Area

• Process Development and Optimization
• Plant / Equipment Performance Monitoring
• Predictive Maintenance
• Quality Control
• Supply Chain Optimization
• Other Application Areas

Utility in Drug Manufacturing

• Defect Detection
• Packaging and Label Inspection
• Package Counting
• Fill Level Inspection
• Other Utilities

Geographical Regions

• North America
• US
• Canada
• Europe
• Germany
• UK
• Italy
• Spain
• France
• Rest of Europe
• Asia-Pacific
• China
• India
• Japan
• Korea
• Australia
• Latin America
• Brazil
• Argentina
• Rest of Latin America
• Middle East and North Africa
• Saudi Arabia
• UAE
• Egypt
• Rest of MENA

Additional Benefits

• Complimentary Dynamic Excel Dashboards for Analytical Modules
• Exclusive 15% Free Content Customization
• Personalized Interactive Report Walkthrough with the Research Team
• Free Report Updates for Versions Older than 6-12 Months

For more information about this report visit https://www.researchandmarkets.com/r/9mt4d2

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: 
CONTACT: ResearchAndMarkets.com 
         Laura Wood, Senior  Press Manager 
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470 
         For U.S./ CAN Toll Free Call 1-800-526-8630 
         For GMT Office Hours Call +353-1-416-8900